Category: Prescription Drugs
Asia Prescription Drugs
-
South Korea Healthcare Supply Chain Management Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... study of the South Korea market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the South Korea market. Also, factors that are driving and restraining the ... Read More
-
China Healthcare Supply Chain Management Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the China market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the China market. Also, factors that are driving and restraining the healthcare supply chain management ... Read More
-
Herpes Simplex Virus Treatment Market, By Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Other Drugs), By Route of Administration (Oral, Injection, and Topical), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 The herpes simplex virus (HSV) is a viral infection that causes genital and oral herpes. It is a very contagious virus that causes infections. ... Read More
-
Asia-Pacific Pharmaceutical Industry Outlook, 2023
... on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan, and Korea leading the space in overall innovative pipeline assets in the region. Compared to ... Read More
-
Rx/Reimbursement Adult Incontinence in Hong Kong, China
... subsidies and reimbursements for adult incontinence products. This scheme offered a safety net for those who are unable to sustain themselves financially, and only older citizens who are enrolled in the CSSA scheme are eligible ... Read More
-
Impact of South Korea on the Pharmaceutical Industry - Thematic Intelligence
... South Korea is a market that offers significant potential for big pharma manufacturing, with domestic companies dominating the marketed product landscape as encouraged by government policy. The top three therapy areas among marketed and pipeline ... Read More
-
Research Report on Southeast Asia Pharmaceutical Industry 2023-2032
... burden of non-communicable diseases, the demand for pharmaceutical consumption and medical and health expenditure in Southeast Asian countries are expanding. According to CRI 's analysis, the Southeast Asian pharmaceutical market has great potential for development. ... Read More
-
Clostridioides Difficile Infection Treatment Market, by Drug Type (Vancomycin, Metronidazole, Fidaxomicin, and Others (late phase drugs, etc.)), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Clostridiodes Difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets ... Read More
-
Asia Pacific Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
... Asia Pacific overactive bladder treatment market is expected to grow from US$ 871.48 million in 2022 to US$ 1,082.25 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to ... Read More
-
Asia Pacific Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)
... The APAC malaria treatment market is expected to grow from US$ 235.63 million in 2022 to US$ 347.39 million by 2028. It is estimated to register a CAGR of 6.7% from 2022 to 2028. Initiatives ... Read More
-
Anti-Obesity Drug Market, By Mechanism of Action (Peripherally Acting Anti-Obesity Drugs and Centrally Acting Anti-obesity Drugs), By Prescription/Non- prescription (Prescription Drugs and OTC Drugs), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Obesity is commonly defined as having too much body mass. Body mass index (BMI) of 30 or higher is the usual benchmark for ... Read More
-
Atopic Dermatitis Market, By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes), By Type of Administration (Topical, Oral, and Injectable), By Prescription Type (Over-the-counter (OTC) and Prescription), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Atopic dermatitis (AD), or eczema, is a chronic condition that causes dry, itchy, ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Philippines Pharmacy Retail Market Size - By Market Structure, By Type of Store Location, By Type of Sales, By Type of Drug, By Therapeutic Class - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
... Retail Market Overview According to SPER Market Research, the Philippines Pharmacy Retail Market is estimated to reach USD XX billion by 2032 with a CAGR of XX%. The Philippines Pharmacy Retail Market is a thriving ... Read More
-
Asia Pacific Cold Pain Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Application (Runner's Knee, Tendonitis, Sprains/Sports Sprain, Arthritis Pain, Pain and Swelling After Hip or Knee Replacement, Pain or Swelling Under Cast or Splint, Surgery Recovery, Lower Back Pain, and Others), Offering (Over-the-Counter, Prescription Products, Rehabilitation Exercises, Ice Wrap & Cold Packs, Pads, Compression Therapy, Ice Buckets Without Compression, and Others), and End User (Hospitals, Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Individuals, and Others)
... Swelling Under Cast or Splint, Surgery Recovery, Lower Back Pain, and Others), Offering (Over-the-Counter, Prescription Products, Rehabilitation Exercises, Ice Wrap & Cold Packs, Pads, Compression Therapy, Ice Buckets Without Compression, and Others), and End User ... Read More
-
Asia-Pacific Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drugs and OTC Drugs)
... Drugs and OTC Drugs) The APAC dry eye products market is expected to grow from US$ 1,298.49 million in 2021 to US$ 1,900.70 million by 2028. It is estimated to grow at a CAGR of ... Read More
-
Pharmaceuticals and Medical Equipment in Asia Pacific
... expected to record the fastest production growth globally, underpinned by its sizeable population, expanding access to healthcare, improving business environment and major investments into research and development. The Pharmaceuticals and Medical Equipment in Asia Pacific ... Read More
-
China COPD & Asthma Market 2022-2028
... setting and Clinics Center) Forecast Period (2021-2028) The China Chronic obstructive pulmonary disease (COPD) & asthma market was valued at around $3.5 billion in 2021 and is estimated to reach nearly $4.7 billion in 2028, ... Read More
-
Eye Inflammation Treatment Market, by Drug Class (Monoclonal Antibodies, Antibiotics, Corticosteroids, Antivirals, Antifungal, Others (Analgesics, etc.)), by Dosage Form (Eye Drops, Tablets, Capsules, Others (Ophthalmic Ointments, etc.)), by Distribution Channels, (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Eye inflammation, also known as ocular inflammation, is a disorder marked ... Read More
-
Acne Medication Market, by Drug Class (Retinoid (Topical Retinoid and Oral Retinoid), Antibiotics (Topical Antibiotics and Oral Antibiotics), Fixed Dose Combinations (Clindamycin + Benzoyl Peroxide, Clindamycin + Tretinoin, Adapalene + Benzoyl Peroxide, Tretinoin + Benzoyl Peroxide and Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide and Others), by Type (Prescription and OTC), by Indication (Inflammatory Acne and Non-Inflammatory Acne), by Formulation (Topical Medication and Oral Medication), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Peroxide and Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide and Others), by Type (Prescription and OTC), by Indication (Inflammatory Acne and Non-Inflammatory Acne), by Formulation (Topical Medication and Oral Medication), by Distribution Channel (Hospital Pharmacies, ... Read More
-
E-pharmacy Market in India 2022-2027
... 2021, the market for online pharmacies was worth INR 25.50 Bn. It is anticipated to expand at a compound annual growth rate (CAGR) of 22.20% from 2022 to 2027, when it is expected to reach ... Read More
-
Japan Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... across the globe are having a profound positive impact on Japanese pharmaceuticals. Most pharmaceutical and biotechnological companies are focusing their R&D departments on identifying new molecules or leads for the treatment of this disease, which ... Read More
-
Pharmaceuticals Industry in India - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... India Pharmaceutical Industry has emerged as greater power amid COVID-19. The growth of the India Pharmaceutical industry is largely supported by the government. The emergence of COVID-19 has led to the health crisis that the ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
Cardiovascular Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous ... Read More
Research Assistance
